Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Davita Inc.

DVA · NYSE · Healthcare

Fundamental quality

REASONABLE

57

out of 100

Breakdown by area

I.GrowthEPS growth: 20.5% · Revenue growth: 5.5%
68
II.ProfitabilityNet margin: 5.6% · ROE: -103.4%
37
III.Financial healthNet debt/EBITDA: 2.85x · FCF: 10.8%
65

Source: SEC EDGAR · TTM through 31/03/2026

The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.

Strengths

  • Growing earnings per share (20.5% annualized).

Risks and weaknesses

  • No clear weaknesses in the recent fundamentals, though the system doesn't assess qualitative factors (competition, regulation, management).

Historical evolution

YearRevenueNet incomeFree cash flowNet debt
202111,6199781,289-462
202211,610560961-244
202312,1406921,491-380
202412,8169361,467-795
202513,6437471,311-676

Between 2021 and 2025, revenue went from $11,619M to $13,643M (+17%) and net income went from $978M to $747M (-24%).

Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.

Frequently asked questions

Is Davita Inc. a profitable company?

Davita Inc. is profitable, with a net margin of 5.6%, though a thin one.

Does Davita Inc. have a lot of debt?

A moderate level: its net debt is 2.85 times its EBITDA.

Is Davita Inc. growing?

Its revenue has grown 5.5% annualized in recent years and its earnings per share 20.5%.

Does Davita Inc. generate cash?

Yes. It converts about 10.8% of its revenue into free cash flow.

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Davita Inc. cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Davita Inc.?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →
Was this page helpful?